WuXi Healthcare Ventures — 2014 Investments

1 investments dated 2014 · listed companies and verified rows first · show all

Syros Pharmaceuticals, Inc.syros.comOct 2014

Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.

Cambridge, US

Nancy Simonian(CEO)

Co-investorsAisling Capital ARCH Venture Partners Quan Capital Alexandria Ally Bridge Group Bain Capital +11 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.